
Opinion|Videos|September 30, 2024
Patient Case 1: A Sixty-Five-Year-Old Man With Prostate Cancer
Author(s)Neal Shore, MD, FACS
Neal Shore, MD, FACS, discusses the progress of a 65-year-old patient with mCRPC through various treatments and evaluation for Lutetium-177 therapy based on his PSMA PET scan and MRI.
Advertisement
Episodes in this series

Now Playing
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Clinical Application of MMAI Score in Patients with Prostate Cancer
2
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
3
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
4
Kevin Zorn, MD, on selecting among different MIST options for BPH
5







